Susquehanna International Group, LLP Moderna, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $74.8 Million - $147 Million	1,175,400 Added 44.65%	3,807,800 $254 Million
Q2 2024 Aug 15, 2024	BUY	$101.21 - $166.61 $68.1 Million - $112 Million	672,400 Added 34.31%	2,632,400 $313 Million
Q1 2024 May 07, 2024	SELL	$85.37 - $115.44 $28.9 Million - $39.1 Million	-339,000 Reduced 14.75%	1,960,000 $209 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $13 Million - $19.6 Million	-187,400 Reduced 7.54%	2,299,000 $229 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $4.43 Million - $5.82 Million	-46,000 Reduced 1.82%	2,486,400 $257 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $20.5 Million - $27.8 Million	173,000 Added 7.33%	2,532,400 $308 Million
Q1 2023 May 16, 2023	SELL	$135.66 - $197.02 $66.3 Million - $96.2 Million	-488,500 Reduced 17.15%	2,359,400 $362 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $63.4 Million - $113 Million	535,900 Added 23.18%	2,847,900 $512 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $1.45 Million - $2.39 Million	-12,300 Reduced 0.53%	2,312,000 $273 Million

952

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.